Ceramide, the product of sphingomyelin (SM) hydrolysis by neutral pH-optimum and magnesium-dependent sphingomyelinase (N-SMase), has been reported to increase in response to several inflammatory stimuli including TNFa and IL-1/3. Thus, it has been suggested that ceramide generation plays an important role in such stimuli-mediated physiological and pathological processes*~9).
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Moreover, cell permeable ceramide analogues or bacterial SMases cause the generation of pro-inflammatory lipid arachidonic acid in some cell types. Therefore, regulation of ceramide generation by an inhibitor of N-SMase may lead to a new way of therapy for inflammation and autoimmune diseases. Thus, inhibitors of N-SMasewere searched for in fermentation products. In our previous studies, scyphostatin10~12) and F-1 1334s13) were found and reported to show inhibitory activity against the enzyme. In addition to their discoveries, one of the strains was found to produce an active metabolite against rat brain N-SMase.The strain was identified to be Micromonospora sp. SANK60294 from its morphological, physiological, and chemotaxonomic charactaristic s.
The N-SMase inhibitor-producing organism was incubated as a vegetative culture in a 500ml Erlenmeyer flask containing 100 ml of vegetative medium(composed of: 2.5% glycerol, 2.5% glucose, 1% pressed yeast, 1% soy been meal, 0.05% K2HPO4, 0.05% MgSO4-7H2O, 0.5% CaCO3, 0.005% CB-422) at 28°C on a rotatory shaker (120rpm) for 5 days. One milliliter of the cultured broth was inoculated into twenty 500 ml Erlenmeyer flasks To analyze the N-SMase inhibition mechanism of macquarimicin A, a kinetic analysis16) was done.
The Lineweaver-Burk plots ( Fig. 2 . left) showed that only Kmvalues were constant against the concentration of SM, revealing the specific pattern for a noncompetitive inhibitor. Also, shown in the Dixon plots ( Fig. 2. right) , the Ki value of macquarimicin A was evaluated to be 70jllm, demonstrating macquarimicin A's weak affinity to rat brain N-SMase. In order to assess the specificity of macquarimicin A, the PGE2generation was dose-dependently inhibited with an IC50 value of6.14jUg/ml as shown in Fig. 3 . Subsequently, the production of IL-1/3, one of the key inflammatory cytokines, was measured after 24 hours of LPS (lO /ig/ml) stimulation. In the experiments shown in Fig. 4 ., macquarimicin A showed a greater, more potent inhibition of IL-1/3 production compared to that of PGE2. Thus, macquarimicin A dose-dependently inhibited the LPS-induced IL-l/J production and a 50% inhibition occurred at 3.46 jig/ml, which is not toxic to the cells (data not shown). This implies that macquarimicin A can be classified as an inhibitor of IL-l/J production, although we are currently unable to offer any speculation on the To evaluate the pharmacological effect of macquarimicin A on acute inflammation in vivo, we performed a carrageenin-induced paw edema study12). As shown in Table  2 , carrageenin-induced paw edema was dose-dependently inhibited by an oral administration of macquarimicin A. Since the generation of the paw edema is largely caused by PGE2, the inhibition with macquarimicin A appeared to be reflected in the PGE2 production inhibition as shown in Fig.  3 . As for the acute toxicity ofmacquarimicin A in vivo, on the other hand, no abnormality in mice was observed for at least 7 days after an oral administration of an excess concentration of 300mg/kg macquarimicin A (data not shown).
Fromthese results and our previous studies regarding anti-inflammatory activities of scyphostatin, it was shown that regulation of ceramide levels by inhibition of N-SMase 
